Phase 1b expansion cohort study to evaluate the safety and efficacy of necitumumab and abemaciclib combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 27; p. vi453
Main Authors Besse, B., Barlesi, F., Ceccarelli, M., Chao, G.Y., Frimodt-Moller, B., Gil, M., Vansteenkiste, J.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2016
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw383.97